{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:12:48Z","timestamp":1738645968632,"version":"3.35.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"DOI":"10.7759\/cureus.78418","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:56:01Z","timestamp":1738590961000},"source":"Crossref","is-referenced-by-count":0,"title":["Racemose Neurocysticercosis Presenting As Vasculitic Infarct and Obstructive Hydrocephalus: A Rare Presentation"],"prefix":"10.7759","author":[{"given":"Rishabh","family":"Rawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinadh","family":"Tummagunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Kampani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrishabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayaz","family":"Hussain Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia HH","year":"2014","unstructured":"Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014, 13:1202-15. 10.1016\/S1474-4422(14)70094-8","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285610395654","article-title":"Neurocysticercosis","volume":"4","author":"Singhi P","year":"2011","unstructured":"Singhi P. Neurocysticercosis. Ther Adv Neurol Disord. 2011, 4:67-81. 10.1177\/1756285610395654","journal-title":"Ther Adv Neurol Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11101212","article-title":"Human neurocysticercosis: an overview","volume":"11","author":"Del Brutto OH","year":"2022","unstructured":"Del Brutto OH. Human neurocysticercosis: an overview. Pathogens. 2022, 11:12. 10.3390\/pathogens11101212","journal-title":"Pathogens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2015.11.3.203","article-title":"Extraparenchymal (racemose) neurocysticercosis and its multitude manifestations: a comprehensive review","volume":"11","author":"Mahale RR","year":"2015","unstructured":"Mahale RR, Mehta A, Rangasetty S. Extraparenchymal (racemose) neurocysticercosis and its multitude manifestations: a comprehensive review. J Clin Neurol. 2015, 11:203-11. 10.3988\/jcn.2015.11.3.203","journal-title":"J Clin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.175881","article-title":"Racemose neurocysticercosis","volume":"7","author":"Krupa K","year":"2016","unstructured":"Krupa K, Krupa K, Pisculli ML, Athas DM, Farrell CJ. Racemose neurocysticercosis. Surg Neurol Int. 2016, 7:12. 10.4103\/2152-7806.175881","journal-title":"Surg Neurol Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2022-S115","article-title":"Update on the diagnosis and management of neurocysticercosis","volume":"80","author":"Takayanagui OM","year":"2022","unstructured":"Takayanagui OM, Haes TM. Update on the diagnosis and management of neurocysticercosis. Arq Neuropsiquiatr. 2022, 80:296-306. 10.1590\/0004-282X-ANP-2022-S115","journal-title":"Arq Neuropsiquiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.5.810-812.2000","article-title":"Serological evaluation of thin-layer immunoassay-enzyme-linked immunosorbent assay for antibody detection in human trichinellosis","volume":"7","author":"G\u00f3mez-Priego A","year":"2000","unstructured":"G\u00f3mez-Priego A, Crecencio-Rosales L, de-La-Rosa JL. Serological evaluation of thin-layer immunoassay-enzyme-linked immunosorbent assay for antibody detection in human trichinellosis. Clin Diagn Lab Immunol. 2000, 7:810-2. 10.1128\/CDLI.7.5.810-812.2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0079","article-title":"Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA\u2122","volume":"84","author":"Lee YM","year":"2011","unstructured":"Lee YM, Handali S, Hancock K, et al.. Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA\u2122. Am J Trop Med Hyg. 2011, 84:587-93. 10.4269\/ajtmh.2011.10-0079","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garc\u00eda HH","year":"2002","unstructured":"Garc\u00eda HH, Evans CA, Nash TE, et al.. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002, 15:747-56. 10.1128\/CMR.15.4.747-756.2002","journal-title":"Clin Microbiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.135","article-title":"Diagnosis and treatment of neurocysticercosis","volume":"7","author":"Nash TE","year":"2011","unstructured":"Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011, 7:584-94. 10.1038\/nrneurol.2011.135","journal-title":"Nat Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/bjrcr\/uaae001","article-title":"Racemose neurocysticercosis: a case series","volume":"10","author":"Sharma S","year":"2024","unstructured":"Sharma S, Singh A, Mani VE, et al.. Racemose neurocysticercosis: a case series. BJR Case Rep. 2024, 10:1. 10.1093\/bjrcr\/uaae001","journal-title":"BJR Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00085-19","article-title":"Taenia solium cysticercosis and its impact in neurological disease","volume":"33","author":"Garcia HH","year":"2020","unstructured":"Garcia HH, Gonzalez AE, Gilman RH. Taenia solium cysticercosis and its impact in neurological disease. Clin Microbiol Rev. 2020, 33:19. 10.1128\/CMR.00085-19","journal-title":"Clin Microbiol Rev"},{"key":"ref13","article-title":"Ring-enhancing lesions in the brain: a diagnostic dilemma","volume":"8","author":"SH G","year":"2014","unstructured":"SH G, AV KS, RA BS. Ring-enhancing lesions in the brain: a diagnostic dilemma. Iran J Child Neurol. 2014, 8:61-4.","journal-title":"Iran J Child Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199401000-00004","article-title":"Neurocysticercosis in Houston, Texas. A report of 112 cases","volume":"73","author":"Shandera WX","year":"1994","unstructured":"Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore). 1994, 73:37-52. 10.1097\/00005792-199401000-00004","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2023.08.023","article-title":"Racemose neurocysticercosis presenting with thalamic stroke: a case report and literature review","volume":"18","author":"Castel\u00e3o F","year":"2023","unstructured":"Castel\u00e3o F, Pais M, Marques D, Sequeira M, Marques C, Rios AC. Racemose neurocysticercosis presenting with thalamic stroke: a case report and literature review. Radiol Case Rep. 2023, 18:3881-3. 10.1016\/j.radcr.2023.08.023","journal-title":"Radiol Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107477","article-title":"A hidden infection: racemose neurocysticercosis causing hydrocephalus; a case report","volume":"98","author":"Welch RL","year":"2022","unstructured":"Welch RL, Bernardin B, Albayar A. A hidden infection: racemose neurocysticercosis causing hydrocephalus; a case report. Int J Surg Case Rep. 2022, 98:107477. 10.1016\/j.ijscr.2022.107477","journal-title":"Int J Surg Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02021-y","article-title":"Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study","volume":"51","author":"Stelzle D","year":"2023","unstructured":"Stelzle D, Makasi C, Schmidt V, et al.. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. Infection. 2023, 51:1127-39. 10.1007\/s15010-023-02021-y","journal-title":"Infection"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.6.3.295","article-title":"Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?","volume":"6","author":"Garcia HH","year":"2008","unstructured":"Garcia HH. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?. Expert Rev Anti Infect Ther. 2008, 6:295-8. 10.1586\/14787210.6.3.295","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336154-racemose-neurocysticercosis-presenting-as-vasculitic-infarct-and-obstructive-hydrocephalus-a-rare-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:56:03Z","timestamp":1738590963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336154-racemose-neurocysticercosis-presenting-as-vasculitic-infarct-and-obstructive-hydrocephalus-a-rare-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.78418","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}